Kurs
+0,63%
Likviditet
1,44 MDKK
Kalender
| Est. tid* | ||
| 2026-02-03 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-21 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-22 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-29 | - | Kvartalsrapport 2025-Q1 |
| 2025-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2025-03-12 | - | Årsstämma |
| 2025-02-05 | - | Bokslutskommuniké 2024 |
| 2024-10-22 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-13 | - | Årsstämma |
| 2024-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2024-03-12 | - | Årsstämma |
| 2024-01-30 | - | Bokslutskommuniké 2023 |
| 2023-10-24 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-25 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2023-03-10 | - | Årsstämma |
| 2023-01-31 | - | Bokslutskommuniké 2022 |
| 2022-10-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-26 | - | Kvartalsrapport 2022-Q1 |
| 2022-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2022-03-08 | - | Årsstämma |
| 2022-02-01 | - | Bokslutskommuniké 2021 |
| 2021-10-26 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-22 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-27 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2021-03-08 | - | Årsstämma |
| 2021-02-02 | - | Bokslutskommuniké 2020 |
| 2020-10-27 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-23 | - | Kvartalsrapport 2020-Q2 |
| 2020-04-30 | - | Kvartalsrapport 2020-Q1 |
| 2020-03-13 | - | X-dag ordinarie utdelning EMBLA 0.15 DKK |
| 2020-03-12 | - | Årsstämma |
| 2020-02-04 | - | Bokslutskommuniké 2019 |
| 2019-10-22 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-25 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-08 | - | X-dag ordinarie utdelning EMBLA 0.14 DKK |
| 2019-03-07 | - | Årsstämma |
| 2019-02-05 | - | Bokslutskommuniké 2018 |
| 2018-10-24 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-25 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-09 | - | X-dag ordinarie utdelning EMBLA 0.13 DKK |
| 2018-03-08 | - | Årsstämma |
| 2018-02-05 | - | Bokslutskommuniké 2017 |
| 2017-10-24 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-10 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
| 2016-03-11 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
| 2016-03-10 | - | Årsstämma |
| 2016-02-02 | - | Bokslutskommuniké 2015 |
| 2015-10-22 | - | Kvartalsrapport 2015-Q3 |
| 2015-07-23 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-29 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-12 | - | Årsstämma |
| 2015-02-05 | - | Bokslutskommuniké 2014 |
| 2014-10-24 | - | Analytiker möte 2014 |
| 2014-10-23 | - | Kvartalsrapport 2014-Q3 |
| 2014-07-25 | - | Analytiker möte 2014 |
| 2014-07-24 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-30 | - | Analytiker möte 2014 |
| 2014-04-29 | - | Kvartalsrapport 2014-Q1 |
| 2014-03-14 | - | Årsstämma |
| 2014-02-05 | - | Bokslutskommuniké 2013 |
| 2013-10-24 | - | Analytiker möte 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-07-24 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-24 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-15 | - | Årsstämma |
| 2013-02-06 | - | Bokslutskommuniké 2012 |
| 2012-11-28 | - | Kapitalmarknadsdag 2012 |
| 2012-11-27 | - | Kapitalmarknadsdag 2012 |
| 2012-10-24 | - | Analytiker möte 2012 |
| 2012-10-23 | - | Kvartalsrapport 2012-Q3 |
| 2012-07-25 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-24 | - | Kvartalsrapport 2012-Q1 |
| 2012-03-16 | - | Årsstämma |
| 2012-02-08 | - | Bokslutskommuniké 2011 |
| 2011-10-27 | - | Kvartalsrapport 2011-Q3 |
| 2011-07-28 | - | Kvartalsrapport 2011-Q2 |
| 2011-03-04 | - | Årsstämma |
Beskrivning
| Land | Island |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Reykjavik, Iceland/Copenhagen, Denmark, 3 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q3 2025 Report on 21 October 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST.
The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.
Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors
To participate in the telephone conference, please use the dial-in details provided below:
DK: +45 78 76 84 90
SE: +46 31-311 50 03
UK: +44 20 3769 6819
US: +1 646 787 0157
Participant access code: 274982
The webcast will be available through following link: Embla Medical Q3 2025 webcast
Financial calendar and events 2025/2026
21 Oct 2025 Interim Report Q3 2025
21 Oct 2025 Q3 2025 HCA Capital virtual presentation and Q&A
21 Oct 2025 Q3 2025 Investor Road Show Copenhagen (Danske Bank)
22-23 Oct 2025 Q3 2025 Investor Road Show Benelux (DNB Carnegie)
23 Oct 2025 Q3 2025 Investor Road Show New York City (DNB Carnegie)
4 Nov 2025 Berenberg Nordic Seminar, Frankfurt
17 Nov 2025 InvestorDagen Dansk Aktionærforening, Copenhagen
19-20 Nov 2025 Jefferies Global Healthcare Conference, London
24 Nov 2025 AktieInfo Investor Event (Retail), Aalborg
25 Nov 2025 DNB Carnegie Healthcare conference
26 Nov 2025 Danske Bank Winter Seminar, Copenhagen
2 Dec 2025 Nordea Focus Seminar, Paris
8 Jan 2025 SEB Nordic Seminar, Copenhagen
3 Feb 2025 Interim Report Q4 2025 & 2025 Annual Report
If you wish to receive Embla Medical press releases by e-mail, please register here
For further information please contact
Klaus Sindahl
Head of Investor Relations
M: +45 5363 0134
About Embla Medical
Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people`s mobility by providing prosthetics, neuro orthotics, bracing & supports and patient care through a global network of orthotic & prosthetic facilities. Embla Medical is committed to sustainable business practices renowned for positively impacting people`s health and well-being.